Sponsor pipeline

Viking Therapeutics, Inc. clinical trial pipeline

Get alerts when Viking Therapeutics, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

First postedNew trial filingPhaseStatus
2026-10-09 NCT07868835 Oral VK2735 for Weight Management Phase 3 (SUNRISE 1) Phase 3 Not Yet Recruiting
2026-10-09 NCT07868939 Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3… Phase 3 Not Yet Recruiting
2026-09-29 NCT07846033 A Phase 1 Study of VK3019 in Overweight and Obese Adults Without Comorbidities Phase 1 Recruiting
2026-09-24 NCT07838740 A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities Phase 1 Recruiting

Active trials by phase

Phase 1
2
Phase 3
4

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07868835 Oral VK2735 for Weight Management Phase 3 (SUNRISE 1) Weight Loss Not Yet Recruiting 2026-10-09
NCT07868939 Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3… Weight Loss Not Yet Recruiting 2026-10-09
NCT07104383 VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) Weight Loss Active, Not Recruiting 2026-04-07
NCT07104500 VK2735 for Weight Management Phase 3 Weight Loss Active, Not Recruiting 2025-11-24
Phase 1
NCT07846033 A Phase 1 Study of VK3019 in Overweight and Obese Adults Without Comorbidities Obese Adults Recruiting 2026-09-29
NCT07838740 A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities Obese Adults Recruiting 2026-09-24

Disease areas by active trials

Get alerts when Viking Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free